Department of Neurosurgery and.
Institute of Neuropathology, University Hospital Münster; and.
J Neurosurg. 2017 Apr;126(4):1201-1211. doi: 10.3171/2016.2.JNS152611. Epub 2016 Jun 3.
OBJECTIVE The purpose of this study was to compare long-term prognosis after meningioma surgery in elderly and younger patients as well as to compare survival of elderly patients with surgically treated meningioma to survival rates for the general population. METHODS Five hundred meningioma patients (median follow-up 90 months) who underwent surgery between 1994 and 2009 were subdivided into "elderly" (age ≥ 65 years, n = 162) and "younger" (age < 65 years, n = 338) groups for uni- and multivariate analyses. Mortality was compared with rates for the age- and sex-matched general population. RESULTS The median age at diagnosis was 71 in the elderly group and 51 years in the younger group. Sex, intracranial tumor location, grade of resection, radiotherapy, and histopathological subtypes were similar in the 2 groups. High-grade (WHO Grades II and III) and spinal tumors were more common in older patients than in younger patients (15% vs 8%, p = 0.017, and 12% vs 4%, p = 0.001, respectively). The progression-free interval (PFI) was similar in the 2 groups, whereas mortality at 3 months after surgery was higher and median overall survival (OS) was shorter in older patients (7%, 191 months) than in younger patients (1%, median not reached; HR 4.9, 95% CI 2.75-8.74; p < 0.001). Otherwise, the median OS in elderly patients did not differ from the anticipated general life expectancy (HR 1.03, 95% CI 0.70-1.50; p = 0.886). Within the older patient group, PFI was lower in patients with high-grade meningiomas (HR 24.74, 95% CI 4.23-144.66; p < 0.001) and after subtotal resection (HR 10.57, 95% CI 2.23-50.05; p = 0.003). Although extent of resection was independent of perioperative mortality, the median OS was longer after gross-total resection than after subtotal resection (HR 2.7, 95% CI 1.09-6.69; p = 0.032). CONCLUSIONS Elderly patients with surgically treated meningioma do not suffer from impaired survival compared with the age-matched general population, and their PFI is similar to that of younger meningioma patients. These data help mitigate fears concerning surgical treatment of elderly patients in an aging society.
本研究旨在比较老年和年轻患者脑膜瘤手术后的长期预后,并比较手术治疗的老年脑膜瘤患者的生存率与普通人群的生存率。
将 1994 年至 2009 年间接受手术的 500 例脑膜瘤患者(中位随访 90 个月)分为“老年”(年龄≥65 岁,n=162)和“年轻”(年龄<65 岁,n=338)组进行单变量和多变量分析。将死亡率与年龄和性别匹配的普通人群的死亡率进行比较。
老年组的中位诊断年龄为 71 岁,年轻组为 51 岁。两组的性别、颅内肿瘤位置、切除程度、放疗和组织病理学亚型相似。与年轻患者相比,老年患者中高级别(世界卫生组织分级 II 和 III 级)和脊髓肿瘤更为常见(15%比 8%,p=0.017,和 12%比 4%,p=0.001)。两组的无进展生存期(PFI)相似,但老年患者术后 3 个月死亡率较高,总生存期(OS)较短(7%,191 个月;中位未达到;HR 4.9,95%CI 2.75-8.74;p<0.001)。否则,老年患者的中位 OS 与预期的一般预期寿命无差异(HR 1.03,95%CI 0.70-1.50;p=0.886)。在老年患者组中,高级别脑膜瘤患者的 PFI 较低(HR 24.74,95%CI 4.23-144.66;p<0.001),次全切除患者的 PFI 较低(HR 10.57,95%CI 2.23-50.05;p=0.003)。尽管切除程度与围手术期死亡率无关,但大体全切除后 OS 较长(HR 2.7,95%CI 1.09-6.69;p=0.032)。
与年龄匹配的普通人群相比,手术治疗的老年脑膜瘤患者的生存并未受损,且其 PFI 与年轻脑膜瘤患者相似。这些数据有助于减轻对老龄化社会中老年患者手术治疗的担忧。